Imbruvica Capsule (Ibrutinib): Targeted Cancer Therapy | For Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma & Other B-Cell Malignancies
Imbruvica Capsule contains ibrutinib, a targeted anticancer medicine used to treat certain blood cancers, including chronic lymphocytic leukaemia (CLL), small lymphocytic lymphoma (SLL), and mantle cell lymphoma (MCL). It works by blocking a protein called Bruton’s tyrosine kinase (BTK), which helps certain cancer cells grow and survive. This action helps slow the growth and spread of abnormal B-cells. It should be taken strictly under the guidance of an oncologist.
Product Overview
Imbruvica Capsule contains ibrutinib, a targeted cancer medicine used to treat certain types of blood cancers, such as chronic lymphocytic leukaemia (CLL), small lymphocytic lymphoma (SLL), and Waldenström's macroglobulinaemia (WM). It works by blocking specific signals that cancerous B-cells need to grow and survive. This helps slow the progression of the disease and supports better control of the condition.
How Does Imbruvica Capsule Work? (Pharmacodynamics)
Ibrutinib works by blocking an enzyme called Bruton's tyrosine kinase (BTK), which plays an important role in the growth and survival of B-cells.
- BTK Inhibition: Ibrutinib blocks BTK activity and interrupts signals that help abnormal B-cells grow and survive.
- Reduced Cancer Cell Activity: This helps limit the growth and spread of certain cancerous B-cells.
- Disease Control: By interfering with these signals, it helps manage the progression of certain blood cancers.
Understanding Its Role in the Body
Imbruvica targets specific pathways involved in abnormal B-cell activity rather than affecting all rapidly dividing cells in the same way as traditional chemotherapy. It helps control the disease, although it may not eliminate all cancer cells. Tr
Expected Results
The response to Imbruvica may develop gradually over weeks or months, depending on the type of blood cancer and individual response. Regular monitoring helps the healthcare professional assess how well the treatment is working. Do not stop treatment without medical advice.
Pharmacokinetics: How the Body Processes It
After taking Imbruvica Capsule, ibrutinib passes through several processes:
Absorption: The medicine is absorbed through the digestive system after oral administration.
Processing: It is mainly broken down in the liver by an enzyme called CYP3A.
Elimination: Most of the medicine is removed through faeces, while a smaller amount is eliminated through urine.
Clinical Considerations
- Bleeding risk: Ibrutinib may increase the risk of bruising and bleeding. Report unusual bleeding or persistent bruises.
- Infections: The medicine may affect immune cell activity, increasing the risk of infections. Report fever or signs of infection promptly.
- Heart health: It may cause irregular heartbeat, high blood pressure, or other heart-related problems. Regular monitoring is important.
- Blood counts: Routine blood tests help monitor changes in red blood cells, white blood cells, and platelets.
- Drug interactions: Certain antibiotics, antifungals, blood thinners, and herbal products may interact with ibrutinib. Inform your doctor about all medicines and supplements you take.
- Pregnancy: Ibrutinib may harm an unborn baby. Discuss pregnancy prevention and breastfeeding restrictions with your healthcare professional.
- Safe use: Take the capsule exactly as prescribed. Do not open, break, or chew it.
Storage Instructions
Store Imbruvica Capsules at room temperature, away from excessive heat, moisture, and direct sunlight. Keep them in their original packaging and out of reach of children. Follow the storage instructions on the product label.
Summary
Imbruvica Capsule (Ibrutinib) is a targeted treatment that helps control certain blood cancers by blocking BTK-related signals involved in abnormal B-cell growth. Following the prescribed treatment schedule, attending regular check-ups, and reporting unusual symptoms are important parts of managing treatment safely.
Precautions
Imbruvica Capsule (Ibrutinib) requires careful monitoring because it may increase the risk of bleeding, infections, changes in blood cell counts, and heart rhythm problems. Certain existing health conditions and other medicines can increase these risks. Following medical guidance and recognising early warning signs are important during treatment.
Before You Start
Discuss bleeding problems: Inform your doctor if you have a history of unusual bleeding, bruising, or blood-clotting disorders.
Mention heart conditions: Tell your doctor if you have an irregular heartbeat, high blood pressure, or a history of heart problems.
Report infections: Inform your doctor about any ongoing or recent infections before starting treatment.
Share your medication list: Mention blood thinners, antiplatelet medicines, antibiotics, antifungals, and herbal supplements, as some may interact with ibrutinib.
Discuss liver problems: Inform your doctor about any liver condition, as it may affect how your body processes the medicine.
Pregnancy and breastfeeding: Discuss potential risks and necessary precautions with your doctor before treatment.
While Using It
Follow the prescribed dose: Take Imbruvica exactly as directed. Do not change the dose or stop treatment yourself.
Watch for unusual bleeding: Report frequent bruising, nosebleeds, bleeding gums, or blood in your urine or stools.
Take infection symptoms seriously: Contact your doctor if you develop fever, chills, persistent cough, or other signs of infection.
Monitor heart-related symptoms: Report palpitations, dizziness, or unusual breathlessness.
Attend regular checkups: Blood tests and other monitoring may be needed to check blood cell counts, liver function, and treatment response.
Check before surgery: Inform your surgeon or dentist that you take ibrutinib, as temporary treatment interruption may be necessary.
Avoid grapefruit and Seville oranges: These may affect how ibrutinib is processed in the body.
When to Seek Medical Help
Severe bleeding: Seek urgent medical attention for uncontrolled bleeding, black stools, or blood in vomit.
Serious infections: Get medical help for high fever or symptoms of a severe infection.
Heart problems: Seek immediate attention for chest pain, fainting, or a very irregular heartbeat.
Unusual neurological symptoms: Sudden severe headache, confusion, or weakness requires urgent assessment.
Note:
Imbruvica Capsule should be used under specialist supervision. Do not start new medicines, stop treatment, or change the dose without consulting your doctor. Regular monitoring helps identify possible complications early.
Usage
Follow your doctor's instructions: Take Imbruvica Capsule (Ibrutinib) exactly as prescribed. The dose and treatment schedule depend on your condition and individual response.
Take it consistently: Swallow the capsule whole with water at approximately the same time each day. Do not open, break, or chew the capsule.
Missed a dose? If you miss a dose, take it as soon as you remember on the same day. Return to your usual schedule the next day. Do not take an extra dose to make up for the missed one.
Check before combining medicines: Inform your doctor about all medicines and supplements you take, especially blood thinners, antifungal medicines, antibiotics, and other treatments that may interact with ibrutinib.
Discuss your medical history: Tell your doctor if you have heart rhythm problems, high blood pressure, bleeding disorders, liver problems, or a history of infections.
Monitor your health: Watch for unusual bruising, bleeding, fever, persistent tiredness, or irregular heartbeat. Report these symptoms to your healthcare professional.
Attend regular check-ups: Blood tests and other follow-ups may be needed to monitor blood cell counts, liver function, and your response to treatment.
Uses
Imbruvica Capsule contains Ibrutinib, a targeted anticancer medicine known as a Bruton tyrosine kinase (BTK) inhibitor. It works by blocking a protein that helps certain abnormal B cells grow and survive. It is prescribed for specific blood cancers and immune-related conditions.
Chronic lymphocytic leukaemia (CLL): Used to manage this type of blood cancer by interfering with the growth and survival of abnormal lymphocytes.
Small lymphocytic lymphoma (SLL): Helps control the growth of abnormal lymphocytes associated with this type of lymphoma.
Waldenström's macroglobulinaemia: Used to manage this rare blood cancer by targeting signals that support abnormal B-cell activity.
Mantle cell lymphoma (MCL): May be prescribed for certain patients with this type of lymphoma, depending on treatment history and approved indications.
Chronic graft-versus-host disease (cGVHD): Used in eligible patients to help manage this complication following certain stem cell transplants.
Summary: Imbruvica Capsule works by targeting specific signals that help abnormal immune cells grow and survive. Take it exactly as prescribed, maintain regular medical follow-ups, and report unusual symptoms or side effects to your healthcare professional. The treatment schedule and suitability depend on the specific condition and individual medical needs.
Side Effects
Imbruvica Capsules contain ibrutinib, a medicine used to treat certain blood cancers and related conditions. It may cause side effects as it affects the activity of specific cells involved in disease progression. The type and severity of side effects can vary depending on the individual and treatment response. Not everyone experiences them.
Common Side Effects
Diarrhoea: You may experience loose or frequent bowel movements.
Nausea: You may feel sick or uncomfortable in your stomach.
Fatigue: You may feel unusually tired or low on energy.
Bruising: You may notice bruises appearing more easily, even after minor bumps.
Muscle and joint pain: Aches or discomfort may occur in different parts of the body.
Low blood cell counts: Reduced levels of certain blood cells may increase the risk of infections, tiredness, or bruising.
Skin rash: You may notice redness, itching, or small rashes.
Swelling: Some people may experience swelling in their hands, feet, or ankles.
Serious Side Effects
Severe bleeding: Unusual bleeding, blood in the urine or stools, or black stools requires immediate medical attention.
Serious infections: Fever, chills, persistent cough, or other signs of infection should be reported promptly.
Heart rhythm problems: An irregular heartbeat, palpitations, dizziness, or shortness of breath needs medical assessment.
High blood pressure: Ibrutinib may increase blood pressure, so regular monitoring is important.
Liver problems: Yellowing of the skin or eyes, dark urine, or unusual abdominal discomfort requires medical attention.
Severe allergic reactions: Facial or throat swelling, difficulty breathing, or widespread rash requires emergency care.
Note: Attend regular blood tests and blood pressure check-ups during treatment. Inform your doctor about blood thinners, other medicines, or supplements you use, as some may increase bleeding or interaction risks. Do not stop or change the dose yourself. Seek immediate medical attention for unusual bleeding, serious infections, breathing difficulties, or heart-related symptoms.
FAQs
1. What is Imbruvica Capsule used for?
Imbruvica Capsule contains ibrutinib and is used to treat certain blood cancers, including chronic lymphocytic leukaemia (CLL), small lymphocytic lymphoma (SLL), and Waldenström's macroglobulinaemia (WM).
2. How does Imbruvica Capsule work?
It blocks a protein called Bruton’s tyrosine kinase (BTK), which helps certain cancer cells grow and survive. Blocking this protein slows down the growth and spread of these cells.
3. How should Imbruvica Capsule be taken?
Swallow the capsule whole with water, exactly as prescribed by your doctor. Do not open, break, chew, or crush it.
4. Can Imbruvica Capsule be taken with food?
Imbruvica Capsule can be taken with or without food. However, avoid grapefruit, grapefruit juice, and Seville oranges, as they may affect the medicine's levels in your body.
5. What are the common side effects of Imbruvica Capsule?
Common side effects may include diarrhoea, tiredness, nausea, muscle or joint pain, bruising, rash, and a higher risk of infections.
6. Can Imbruvica Capsule increase the risk of bleeding?
Yes. Ibrutinib can affect blood clotting and increase the risk of bleeding. Contact your doctor if you notice unusual bruising, nosebleeds, blood in your urine, or black stools.
7. Can Imbruvica Capsule affect heart health?
Yes. It may cause heart rhythm problems, including atrial fibrillation, and sometimes high blood pressure. Inform your doctor if you experience palpitations, chest discomfort, dizziness, or breathlessness.
8. Can Imbruvica Capsule be taken with other medicines?
Some medicines, particularly certain antifungals, antibiotics, blood thinners, and seizure medicines, can interact with ibrutinib. Always inform your doctor about your current medicines and supplements.
9. What should I do if I miss a dose of Imbruvica Capsule?
If you miss a dose, take it as soon as you remember on the same day. If you remember the next day, skip the missed dose and continue with your regular schedule. Never take an extra dose to make up for it.
10. How long should Imbruvica Capsule be taken?
Treatment is generally continued as prescribed until the condition progresses, side effects become difficult to manage, or your doctor advises stopping. Do not stop or change the dose without medical guidance.
Interactions
Imbruvica Capsules contain ibrutinib, which may interact with certain medicines and supplements, potentially increasing the risk of bleeding, affecting heart rhythm, or changing the amount of medicine in the body. Inform your healthcare professional about all medicines you take before starting treatment.
1. Blood-Thinning Medicines
Medicines such as warfarin, apixaban, and rivaroxaban may increase the risk of bleeding when combined with ibrutinib.
Tell your healthcare professional if you take blood thinners or have a history of bleeding problems.
2. Painkillers (NSAIDs)
Medicines such as ibuprofen, naproxen, and diclofenac may increase the risk of bleeding.
Check with your healthcare professional before using these painkillers.
3. Certain Antibiotics
Medicines such as clarithromycin and erythromycin may increase ibrutinib levels in the body, potentially increasing side effects.
Your doctor may need to adjust your treatment.
4. Antifungal Medicines
Medicines such as ketoconazole, itraconazole, and voriconazole may increase ibrutinib levels.
Inform your healthcare professional if you are taking medicines for fungal infections.
5. Medicines for Seizures
Medicines such as carbamazepine and phenytoin may reduce ibrutinib levels, potentially making treatment less effective.
Tell your doctor if you take medicines for epilepsy.
6. Heart and Blood Pressure Medicines
Certain medicines, such as diltiazem and verapamil, may increase ibrutinib levels and require medical review.
Inform your healthcare professional about any medicines you take for heart or blood pressure conditions.
7. Herbal Supplements
Supplements such as St. John's wort may affect ibrutinib levels and reduce its effectiveness.
Discuss herbal products and supplements before using them during treatment.
Tips to Avoid Interactions
Share a complete list of your prescription medicines, painkillers, vitamins, and herbal supplements.
Do not start new medicines or supplements without medical advice.
Avoid taking over-the-counter painkillers without checking with your healthcare professional.
Follow the prescribed dose and attend recommended blood tests and check-ups.
Note: Not every combination causes a problem, but some may require dose adjustments or closer monitoring. Never stop or change Imbruvica treatment or other regular medicines without consulting your healthcare professional.
| Manufacturer | : | Janssen Pharmaceuticals |
| Equivalent Brand | : | Imbruvica |
| Generic Search | : | Ibrutinib |



























